Mohit Kehar

Investigator, CHEO Research Institute

Dr. Kehar has joined the Division of Pediatric Gastroenterology, Hepatology, and Nutrition as a staff physician on November 1st, 2020. Dr. Kehar was born in India where he completed his pediatrics and pediatric gastroenterology training. He completed his Pediatric Gastroenterology, Hepatology and Nutrition Fellowship at Hospital for Sick Children and worked as locum staff. He moved to Queens University in 2018 as an Assistant Professor and was the clinical lead of the section of Pediatric Gastroenterology before moving to CHEO.

Research interests: Pediatric non-alcoholic fatty liver disease, Pediatric Hepatology

Research areas: Hepatology, Gastroenterology

Research Projects

  1. Awareness, management, and practice patterns of pediatric NAFLD by primary care physicians

    27/08/2021

    Dissemination and implementation of clinical guidelines have the potential to improve knowledge and screening rates for NAFLD in children at the primary-care level.

  2. North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Position Paper on the Diagnosis and Management of Pediatric Acute Liver Failure

    05/08/2021

    we will provide clinical guidance to pediatric gastroenterologists and other pediatric providers caring for children with PALF by presenting the most recent advances in diagnosis, management, pathophysiology, and associated outcomes.

  3. SARS-CoV2 Infection in Children with Liver Transplant and Native Liver Disease: An International Observational Registry Study

    16/02/2021

    Future controlled studies are needed to evaluate effective treatments and further stratify LD and LT patients with SARS-CoV2 infection.

  4. Conversion from tacrolimus to sirolimus as a treatment modality in de novo allergies and immune-mediated disorders in pediatric liver transplant recipients

    19/05/2020

    Immunosuppression conversion from tacrolimus to sirolimus can be an effective therapy in patients suffering severe or treatment-resistant PTAID, suggesting a potential role for tacrolimus in the pathogenesis of PTAID.

  5. Liver transplantation for Gaucher disease presenting as neonatal cholestasis: Case report and literature review

    23/04/2020

    Neurological sequelae may manifest later making the decision to proceed with liver transplantation a difficult one.